BioNeutra Global Corp Cash Flow-to-Debt Ratio

Latest as of September 2024: 0.00x

BioNeutra Global Corp cash flow-to-debt ratio. BioNeutra Global Corp (BGA) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2024, meaning its operating cash flow of CA$33.44K could theoretically repay 0% of its total liabilities (CA$21.81 Million) in one year. Check cash flow reinvestment rate of BioNeutra Global Corp to assess the company's total reinvestment commitment from operating cash flow.

CF-to-Debt Ratio

0.00x
Operating CF / Total Liabilities

Operating Cash Flow

CA$33.44K
CAD

Total Liabilities

CA$21.81 Million
CAD

Data as of

Sep 2024
Most recent filing

Cash Flow-to-Debt Ratio of BioNeutra Global Corp (2013–2023)

Cash flow-to-debt ratio of BioNeutra Global Corp from 2013 to 2023. Historical debt coverage capacity for BioNeutra Global Corp across 11 annual periods. Check cash flow quality index of BioNeutra Global Corp to evaluate the quality of earnings relative to operating cash generation.

BioNeutra Global Corp Cash Flow-to-Debt Ratio by Year (2013–2023)

BioNeutra Global Corp cash flow-to-debt ratio by year from 2013 to 2023. Year-by-year debt coverage analysis for BioNeutra Global Corp. For the full cash flow conversion analysis, see how efficiently does BioNeutra Global Corp generate cash.

Year CF-to-Debt Ratio Operating CF (CAD) Total Liabilities YoY Change
2023 0.03x CA$683.42K CA$21.96 Million ▼ -12.6%
2022 0.04x CA$838.39K CA$23.54 Million ▲ +190.7%
2021 0.01x CA$271.05K CA$22.12 Million ▼ -80.4%
2020 0.06x CA$1.43 Million CA$22.98 Million ▲ +158.0%
2019 0.02x CA$707.55K CA$29.27 Million ▼ -81.8%
2018 0.13x CA$2.91 Million CA$21.93 Million ▲ +0.4%
2017 0.13x CA$2.25 Million CA$17.01 Million ▲ +170.5%
2016 0.05x CA$1.02 Million CA$20.81 Million ▲ +17.5%
2015 0.04x CA$481.50K CA$11.59 Million ▼ -90.6%
2014 0.44x CA$1.41 Million CA$3.19 Million ▲ +86.7%
2013 0.24x CA$1.01 Million CA$4.25 Million —
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.